Shanghai Kuitedi Biotechnology

Shanghai Kuitedi Biotechnology is an innovative drug discovery company based in Shanghai, China, specializing in DNA-encoded library (DEL) technology. Founded in 2021, the company integrates high-throughput screening with artificial intelligence to identify novel small molecule leads for challenging biological targets. Kuitedi's platform is designed to significantly accelerate the early stages of drug development by screening billions of compounds simultaneously. The company operates as both a service provider for pharmaceutical partners and an internal developer of therapeutic programs. Its primary research focus includes oncology and inflammatory diseases. By combining chemical biology with computational tools, Kuitedi aims to improve the efficiency and success rate of lead discovery.